Intellectual Property India Publishes Patent Application for 'Imidazo[1,2-A]pyridine Compounds For Use In Treating Cancer And Inflammatory Diseases And Methods To Prepare Said Compounds' Filed by Theranib Inc.

MUMBAI, India, March 14 -- Intellectual Property India has published a patent application (202517121322 A) filed by Theranib Inc., Halifax, Canada, on Dec. 3, 2025, for 'imidazo[1,2-a]pyridine compounds for use in treating cancer and inflammatory diseases and methods to prepare said compounds.'

Inventor(s) include La Motta, Concettina; Marcato, Paola; Fernando, Wasundara; Maclean, Maya; Dean, Cheryl; Petrarolo, Giovanni; Bernardoni, Bianca Laura; and D'Agostino, Ilaria.

The application for the patent was published on March 13, under issue no. 11/2026.

According to the abstract released by the Intellectual Property India: "The present invention relates to ALDH1 A inhibitor compound isoforms according to Formula (I) and pharmaceutical comp...